Tough and Osteocompatible Calcium Phosphate Cements Reinforced with Poly(vinyl alcohol) Fibers by Kucko, N.W. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/203964
 
 
 
Please be advised that this information was generated on 2020-09-10 and may be subject to
change.
Tough and Osteocompatible Calcium Phosphate Cements
Reinforced with Poly(vinyl alcohol) Fibers
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ABSTRACT: Injectable, self-setting calcium phosphate cements (CPCs) are favorable bone substitutes due to their
osteocompatibility. However, due to their brittleness and low toughness, their clinical application is limited to non-load-bearing
sites. The incorporation of poly(vinyl alcohol) (PVA) fibers into cementitious materials is a successful strategy in civil
engineering for improving the mechanical performance of cements. However, PVA fibers in particular have not yet been applied
to reinforce CPCs. Therefore, the aim of this study is to investigate the effect of PVA fibers on the mechanical properties of
CPCs. Second, the in vitro cytocompatibility of these fibers is studied using cell culture tests. Finally, the in vivo
osteocompatibility of PVA fiber-reinforced CPCs is studied after a 6 and 12 week implantation period in the femoral condyle of
rabbits. Results reveal that the incorporation of PVA fibers into CPCs is a highly effective strategy to strengthen and toughen
CPCs, since the flexural strength and toughness of CPCs increased by more than 3-fold and 435-fold, respectively, upon
reinforcement with PVA fibers. In vitro cytocompatibility tests indicate that PVA fibers are cytocompatible, which is further
confirmed by the in vivo results that show that PVA fibers do not compromise the excellent osteocompatibility of CPCs.
KEYWORDS: calcium phosphate cements, fiber-reinforcement, biomedical applications, poly(vinyl alcohol) fibers,
mechanical properties
1. INTRODUCTION
Calcium phosphate cements (CPCs) are a class of bioceramics
characterized as injectable, self-setting bone substitute
materials. Apatite-forming CPCs share a chemical composition
similar to that of the inorganic component (i.e., hydrox-
yapatite) found in native bone, providing them with favorable
osteocompatible properties.1−5 These characteristics, coupled
with the fact that CPCs are injectable, set under physiological
conditions, and can be utilized in minimally invasive surgical
procedures,6,7 has allowed CPCs to stand out as an attractive
alternative to other routine bone healing treatments (e.g.,
autografts) and other conventional bone substitute materials
(e.g., bioceramic granules).8,9
Since their discovery in the early 1980s by Brown and
Chow,10 CPCs have undergone significant research in an effort
to improve their clinical handling, biodegradation, and
mechanical properties. Nevertheless, CPCs still lack the
mechanical properties needed to be utilized in load-bearing
anatomical sites due to their inherent brittleness and poor
strength and toughness when compared to those of native
bone.5,11−13 This, in turn, has severely restricted their clinical
applicability to surgeries such as tibial plateau augmentation
and the treatment of certain maxillo-craniofacial defects, all of
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which are mainly loaded in compression where CPCs can
withstand greater loads as compared to tension where they are
more prone to failure.3,11,13
Successful improvement of the mechanical strength and
especially toughness of CPCs would significantly expand their
clinical applicability5,12 to more load-bearing defect sites such
as vertebroplasty, kyphoplasty,8,9,14 long bone replacement,15
and fixation of articulating prostheses.16 Therefore, several
strategies have been used in an attempt to reduce the
brittleness and increase the toughness of CPCs, including
both intrinsic and extrinsic approaches.2,5,17 Some of the most
common approaches include (1) reducing the porosity of the
CPC matrix,17,18 (2) the use of a dual setting cement system
involving the cross-linking of polymeric monomers,19,20 and
(3) the reinforcement with fibers,2−5,12,16 with the latter being
the most popular and successful approach to date. This
strategy has been adopted from traditional fields of engineering
such as civil engineering, where fiber-reinforcement of
concretes and hydraulic cements to improve their mechanical
integrity has been extensively used for building purposes.21
Various types of fibers have been incorporated into CPCs in
the form of inorganic whiskers22,23 as well as degradable and
nondegradable polymeric fibers2,3,12 in either short16,24 or long,
discontinuous lengths.17,25
The mechanical performance of fiber-reinforced CPCs is
dictated by a complex interaction between the various
constituents of the composite material which involves (i)
fiber bridging, (ii) crack deflection, and (iii) frictional sliding.
Fiber bridging becomes operational when the matrix begins to
crack under an applied load and the fibers bridge the crack
together, effectively arresting further crack propagation. Crack
deflection occurs when fibers act as a barrier for cracks to grow
and in doing so prolongs the distance at which the crack needs
to travel through the matrix, resulting in more energy
dissipation.21,26,27 Frictional sliding transpires when fibers are
pulled out of the matrix against frictional stress at the fiber−
matrix interface. This phenomenon allows for a stress transfer
whereby the load applied on the matrix is dissipated to the
fibers, effectively absorbing more energy.28
Several key parameters determine the effectiveness of the
above-mentioned fiber-reinforcing mechanisms and mechan-
ical performance of the resulting CPCs including fiber aspect
ratio, concentration, orientation and dispersion, tensile
strength and elastic modulus, biocompatibility, and affinity
toward the matrix.2,12 Within CPC research, the importance of
the fiber−matrix affinity has been poorly addressed.2,17
Biodegradable polyester-based fibers have been used most
extensively to reinforce CPCs. Nevertheless, these fibers are
mechanically weak and hydrophobic, which compromises their
affinity for hydrophilic cement matrices. Consequently, typical
fiber-reinforcement efficacies for CPCs are poor as compared
to reinforcement of cementitious matrices in civil engineer-
ing.2,17 In civil engineering, fibers made of poly(vinyl alcohol)
(PVA) are frequently used to improve the strength and
toughness of cementitious matrices in view of their favorable
mechanical properties, hydrophilicity, and strong affinity for
the inorganic matrix.28−30 However, these fibers have not yet
been used for reinforcement of bioceramic cements. Therefore,
we hypothesize that reinforcement of CPCs with PVA fibers
allows for substantial improvement of the reinforcing efficacy
of CPCs without harming the favorable biological performance
of these bioceramic materials.
Specifically, the hydrophilic nature of PVA fibers should
allow for a strong affinity with hydrophilic CPCs.28−30 In
addition, PVA fibers are stronger and stiffer when compared to
other nondegradable fibers used for reinforcement of CPCs
like nylon, polypropylene, and polyethylene.30 Finally, PVA is
regarded as a biocompatible polymer in the biomedical field, as
evidenced by its use in biomedical applications that range from
hydrogels used in ophthalmic applications to meniscus and
cartilage replacements in orthopedics.31,32 Previously, PVA has
been added as a soluble nonfibrous additive to CPCs, but PVA
fibers have never been incorporated into CPCs.33
In the present study, we investigate the effect of PVA fibers
on the mechanical and biological properties of CPCs by
varying the fiber concentration (2.5−5 wt %) and length (3−6
mm). Two types of commercially available PVA fibers with or
without a hydrophobic surface coating were selected to
decipher how the fiber−matrix affinity influences these
mechanical and biological properties. As CPCs are inherently
brittle, they are weaker under tensile and shear forces which
occur at load-bearing sites within the body. Generally,
compression testing is not recommended for mechanical
testing of the performance of fiber-reinforced CPCs.2 There-
fore, CPCs were subjected to a standard three-point flexural
test to measure their flexural strength, flexural modulus, and
work-of-fracture (as a measure for toughness) since these
properties are key factors in predicting the load-bearing
capacity of CPCs.3 Further, an in vitro cytocompatibility test
was performed on the PVA fibers to determine their
cytocompatibility. Finally, the osteocompatibility of both
resorbable and nonresorbable PVA fiber-reinforced CPCs
was assessed upon implantation in the femoral condyle of
rabbits.
2. MATERIALS AND METHODS
2.1. Preparation of Fiber-Reinforced Calcium Phosphate
Cements. The powder phase of the calcium phosphate cement
(CPC) consisted of 100% α-tricalcium phosphate kindly provided by
CAM Bioceramics B.V. (Leiden, The Netherlands), while the liquid
phase consisted of a 4 wt % NaH2PO4·2H20 (Merck, Darmstadt,
Germany) aqueous solution. Two commercially available poly(vinyl
alcohol) (PVA) fibers were selected for this study: (i) PVAKura fibers
kindly provided by Kuraray Europe GmbH (Kuralon, item
#RMS702/6 mm, Hattersheim am Main, Germany), and (ii) PVAMini
fibers kindly provided by MiniFIBERS Inc. (PVOH, Johnson City,
TN, USA). PVAMini fibers were hydrophilic in nature due to the
absence of any surface modification, whereas PVAKura fibers were
modified with a proprietary hydrophobic coating.
Fabrication of fiber-reinforced CPCs was initiated by adding PVA
fibers to the powder phase of the cement in amounts specified in
Table 1. Next, the liquid phase was added to the powder phase at a
liquid-to-powder ratio of 1:2. The phases were then thoroughly mixed
together for 1 min until a cementitious paste was formed.
Subsequently, the paste was placed in polydimethylsiloxane
(PDMS) molds (25 × 4 × 4 mm), clamped between two glass slides
and allowed to set for 24 h at room temperature. After setting, the
specimens were immersed in phosphate-buffered saline solution
(PBS) and placed on a shaker table set to 120 rpm in an incubator at
Table 1. PVA Fiber Specifications
fiber type
fiber amount
[wt %]
length
[mm]
fiber
diameter
[μm]
aspect ratio
[length/diameter]
PVAKura 2.5 and 5.0 3 and 6 26 115 and 231
PVAMini 2.5 and 5.0 3 and 6 14 214 and 429
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37 °C for 72 h to allow the CPC to fully cure. Mechanical testing was
performed immediately after removing the cement specimens from
the PBS solution in order to ensure testing was performed under wet
conditions.
2.2. Characterization of CPC and PVA Fibers. 2.2.1. Powder
X-ray Diffraction. A PANalytical X’Pert3 powder X-ray diffractometer
(Malvern Panalytical B.V., Eindhoven, The Netherlands) with a Cu
Kα radiation source was employed to perform powder X-ray
diffraction (XRD) on CPC before and after the setting reaction as
specified in section 2.1 in order to characterize the phase
transformation. Further, XRD was also performed on PVAKura and
PVAMini fibers to compare their crystallinity. The measurements were
performed at a voltage and current of 45 kV and 40 mA, respectively,
with a step size of 0.05° and a count time of 3.0 s per step. For the
fiber-free CPC specimens, the scan was from 20° to 60° 2θ, and for
the PVA fibers, the scan was from 10° to 40° 2θ.
2.2.2. Fourier Transform Infrared Spectroscopy. Fourier trans-
form infrared spectroscopy (FTIR, Spectrum One, PerkinElmer Inc.,
Waltham, Massachusetts, USA) was performed on PVAKura and
PVAMini fibers, and their representative spectra were compared with
one another to characterize any chemical differences. Spectra were
measured under attenuated total reflectance (ATR) with a spectral
resolution of 4 cm−1 at 4 scans per measurement. Prior to each
measurement, a background scan was performed in open air at room
temperature. Finally, each spectrum was normalized by performing a
ATR and baseline correction followed by smoothing using Spectrum
10 software (PerkinElmer Inc.).
2.3. Mechanical Testing. A universal testing machine (Lloyd
Instruments Ltd., Bognor Regis, UK) was used to perform a standard
three-point flexural test on the fiber-reinforced CPC specimens using
a support span of 20 mm. A 100 N loading cell was used with a
crosshead speed of 1 mm/min for fiber-reinforced cements and 0.2
mm/min for fiber-free cements. The crosshead speed was increased
for fiber-reinforced CPCs because the crack growth for these
specimens was slower which can interfere with the measurement.
Therefore, it is recommended in ASTM C1161-02CStandard Test
Method for Flexural Strength of Advanced Ceramics at Ambient
Temperature that a crosshead speed of 1.0 mm/min should be used
when this is the case. The flexural strength (S), flexural modulus (E),
and work-of-fracture (WOF) were then measured from the load−
displacement curves as described in eqs 1, 2, and 3, respectively.
There were 10 specimens measured for each CPC composition.
=S P L
bh
flexural strength:
3
2
max
2 (1)
In this equation, Pmax represents the maximum load on the load−
displacement curve, L is the support span, and b and h indicate the
specimen’s width and height, respectively.4,34
=E mL
bh
flexural modulus:
4
3
3 (2)
In this equation, m indicates the slope of the line tangent to the linear-
elastic portion of the load−displacement curve.4,34
‐ ‐ = A
bh
work of fracture: WOF
(3)
In this equation, A indicates the total area under the load−
displacement curve. In the literature, work-of-fracture is commonly
referred to as the toughness of the material and is typically measured
in kilojoules per meter squared (kJ m−2). In order to allow for a
consistent calculation of the WOF, all tests were stopped at a
displacement of 3 mm.
2.4. In Vitro Cytocompatibility Assay. The cytocompatibility of
both PVAMini and PVAKura fibers was assessed by measuring the
proliferation of osteoblastic cells (MC3T3-E1; ATCC, USA) cultured
in the presence or absence of different concentrations of PVA fibers. A
fiber-free group consisting of osteoblastic cells cultured in the absence
of PVA fibers was also included as a positive control. The selected
PVA fiber concentrations ranged between 0.1 and 3 mg mL−1. Fibers
were weighed in Transwell permeable supports (4 μm pore size,
Merck KGaA, Darmstadt, Germany), after which each support was
immersed in 70% ethanol (v/v) for 15 min, followed by two washing
cycles using sterilized PBS. MC3T3-E1 cells were cultured in α-
minimum essential medium (α-MEM, supplemented with 10% fetal
bovine serum and 1% Gentamicin, Gibco, Life Technologies Grand
Island, USA). Cells were seeded at a density of 10 000 cells cm−2 in
polystyrene 12 well-plates and cultured for 24, 48, 72, and 168 h
(medium was replaced after 72 h). After each time point, the medium
and transwell supports were discarded and cells were washed twice
using PBS, followed by the addition of Milli-Q water (2 mL per well)
and 2 freeze cycles. Cellular DNA content was measured using a
Quant-IT PicoGreen ds-DNA assay kit (Invitrogen; Breda, The
Netherlands) according to the manufacturer’s instructions. Briefly,
samples or standard solution (100 μL) was added to a working
solution in a 96-well plate. The plates were then incubated for 5 min
in the dark at room temperature, and the fluorescence emission was
read (excitation, 485/20 nm; emission, 530/25 nm).
2.5. In Vivo Biocompatibility Assay. All animal experiments
were conducted in the Central Animal Laboratory at Sichuan
University, China. The protocols were approved by the Animal
Ethical Committee of Sichuan University and were performed
according to the Chinese national guidelines for the care and use of
laboratory animals. Healthy, skeletally mature, male New Zealand
white rabbits, weighing 3 ± 0.5 kg, were used for this study. The
rabbits were housed separately and given 1 week to acclimate to the
animal laboratory, after which the surgeries were performed. The
animals were fed with rabbit chow and water ad libitum throughout
the study period along with close monitoring for any clinical signs of
discomfort (e.g., weight loss, distress, or behavioral alterations).
2.5.1. Preparation of Materials for Implantation. Four exper-
imental groups were selected as described in Table 2. Poly(D,L-lactic-
co-glycolic acid) particles (PLGA, lactic/glycolic acid ratio of 50/50;
molecular weight of 17 kDa; acid-terminated, Corbion Purac B.V.,
Gorinchem, The Netherlands) were included in two experimental
groups as porogens to accelerate the degradation of the CPC matrix,
as demonstrated previously.35−37 Preset cylindrical specimens (5 × 5
mm2) were prepared by using the same preparation method used for
the mechanical tests. After preparation, the specimens were immersed
in PBS and sterilized with ethylene oxide (Synergy Health, Venlo, The
Netherlands).
2.5.2. Surgical Implantation Procedure. Each rabbit was subjected
to a one-session surgical procedure, in which two formulations were
randomly implanted bilaterally (i.e., one in each femoral condyle).
Randomization was ensured by distributing the experimental groups
over the recipient sites per implantation period according to a
randomization scheme. All surgical procedures were performed with
the animals under general anesthesia, induced by ear vein injection of
3% sodium pentobarbital (Sinopharm Chemical Reagent Co., Ltd.,
Shanghai, China), at a dose of 45 mg kg−1. To reduce the risk of
perioperative infection, the rabbits received antibiotic prophylaxis 30
min prior to surgery and for 3 days postsurgery, by an intramuscular
injection of benzylpenicilin sodium 0.48 g. After anesthesia, rabbits
were immobilized on their backs, and the hind limbs were shaved,
washed, and disinfected with povidone-iodine. A longitudinal skin
incision was performed over the medial femoral condyle, followed by
blunt dissection and removal of the periosteum. Once the medial
condyle was fully exposed, a trephine drill was used to create a 5 mm
Table 2. Compositions of the Solid Phase of Implanted
CPCs
implant type
CPC
[wt %]
PLGA
[wt %]
PVA fibers [wt %]
(6 mm in length)
fiber-free CPC 100.0
CPC/PLGA 60.0 40.0
CPC/PLGA/PVAMini 58.5 39.0 2.5
CPC/PVAMini 97.5 0.0 2.5
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round bone defect to a depth of 5 mm. The preset cylindrical CPC
composites from either of the four experimental groups prepared
previously were press-fitted into the bone defect. Soft tissues were
then closed in separate layers using resorbable single sutures (Vicryl
3-0, Ethicon, Inc., Chaoyang District, Beijing, China). Postoperative
analgesia was administered for 2 days by an intramuscular injection of
xylazin hydrocholoride (Biochemistry Co. Ltd., Shanghai) at a dose of
0.1 mg kg−1. Finally, after the selected implantation periods of 6 and
12 weeks, animals were sacrificed with an overdose of sodium
pentobarbital.
2.5.3. Specimen Retrieval and Histological Processing. After
euthanasia, both femora were retrieved and closely analyzed for any
adverse reactions in the tissue and surrounding structures. After
inspection, the femoral condyle was excised and adhering soft tissues
were removed using a diamond saw and a scalpel, respectively. The
isolated specimens were then fixated in a 4% phosphate-buffered
formalin solution (pH 7.2), dehydrated in a graded series of ethanol
concentrations (70−100%), and finally embedded in poly(methyl
methacrylate) (PMMA). After polymerization, three histological
sections of ∼10 μm in thickness were prepared in a cross-sectional
direction (i.e., perpendicular to the longitudinal direction of the bone
defect) using a saw microtome with a diamond blade (SP 1600, Leica
Microsystems AG, Wetzlar, Germany). The sections were stained
with methylene blue and basic fuchsine and imaged using a digital
slide scanner (VS120-S5; Olympus, Tokyo, Japan) for further analysis.
2.5.4. Histological and Histomorphometrical Analysis. Digital
histology images were analyzed according to a standard developed by
the International Organization for Standardization (Biological
evaluation of medical devices, Part 6Tests for local ef fects af ter
implantation; ISO 10993-6). Briefly, this method relies on comparison
of the biological response of experimental test specimens to the
biological response of control specimens. Control specimens are
defined as materials of which clinical acceptability and/or
biocompatibility characteristics have been previously established.
For this study, fiber-free CPC and CPC/PLGA were considered as
control groups for our PVA-reinforced test groups CPC/PVAMini and
CPC/PLGA/PVAMini, respectively. In more detail, this standard
categorizes the biological response in terms of four main biological
processes, i.e., inflammation, neovascularization, fibrosis, and/or fatty
infiltrate. Four specimens were tested for each experimental or control
group (n = 4). Scores ranged from 0 to 4 depending on the frequency
and/or severity of the observed processes. Subsequently, scores of the
four main biological processes were added together. Finally, the
average score for the control groups was subtracted from the average
score obtained for the experimental test groups. This final total score
categorized the experimental test materials as nonirritant (score
between 0 and 2.9), slightly irritant (score between 3 and 8.9),
moderately irritant (score between 9 and 15), or severely irritant
(score exceeding 15). More details on this scoring method derived
from ISO 10993-6 can be found in the Supporting Information
(Table S1).
Histomorphometrical parameters such as the presence of newly
formed bone and material remnants inside the region-of-interest
(ROI) were determined quantitatively. To this end, the ROI was
defined as the bone defect area that was filled with the preset
cylindrical cement (5 mm in diameter), and images were processed
using image processing software (ImageJ, National Institutes of
Health, Bethesda, Maryland, USA). To define the ROI graphically, a 5
mm circle was superimposed on each image and centered around the
bone defect. The outside of the circle was removed, and the area of
newly formed bone, as well as the remaining material, was determined
on the basis of color recognition with manual correction and
expressed as a percentage of bone or material within the total area of
the ROI, respectively.
2.5.5. Crack Length Determination. The total length of cracks
detectable inside the ROI of fiber-free CPC and CPC/PVAMini
specimens was measured using ImageJ. Samples containing PLGA
were excluded from this analysis since their degradable nature did not
allow for a clear detection of cracks. Additionally, preset cylindrical
fiber-free CPC and CPC/PVAMini control specimens were created and
processed in the same way as the implanted specimens. Sections of
these nonimplanted specimens were processed and imaged as
described above to measure the total crack length per sample prior
to implantation.
2.6. Examination of Morphology of Fiber-Reinforced CPCs.
2.6.1. Scanning Electron Microscopy. To evaluate the CPC surface
morphology and fiber−matrix interface, fractured specimens were
sputter-coated with a 20 nm thick chromium layer and imaged using a
scanning electron microscope (SEM; Zeiss Sigma 300, Zeiss AG,
Oberkochen, Germany). PVA fibers were also evaluated using SEM
before and after cell culture for 168 h to decipher any changes in the
surface morphology.
2.6.2. Nanocomputed Tomography Analysis. Nanocomputed
tomography (nanoCT) was performed on all CPCs selected for in
vivo testing to visualize the dispersion of the fibers within the cement
matrix. Specimens were scanned using a GE Phoenix Nanotom M
nanoCT system, research edition (General Electric, Brussels,
Belgium), with the X-ray source parameters having a voltage of 90
kV, a current of 110 μm, and a focal spot size of 2.34 μm. Acquisition
parameters included an exposure time of 500 ms that produced an
image with a pixel size of 3072 × 2400.
2.7. Statistical Analysis. All values from this study were
presented as a mean ± standard deviation. All statistical analysis
was conducted using GraphPad Prism software (version 7.0d,
GraphPad Software Inc., San Diego, USA) with a level of significance
of p < 0.05.
2.7.1. Analysis of Mechanical Properties. A Grubbs’ outlier test
(significance level = 0.01) was performed on the WOF values for all
specimens, and any outliers were subsequently removed from the data
Figure 1. Powder X-ray diffractograms of (A) the CPC powder precursor phase before and after fully setting and (B) PVA-only fibers. The circles
in Figure 1A represent diffraction peaks characteristic of α-TCP according to Powder Diffraction File ICDD 9-348, and squares represent
diffraction peaks characteristic to hydroxyapatite according to Powder Diffraction File ICDD 9-432. The dotted line in Figure 1B represents the
(101) reflection at 19.4° 2θ, indicative of PVA in both PVAKura and PVAMini fibers.
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set. A two-way analysis of variance (ANOVA) with a posthoc
Bonferroni test was used to statistically analyze the mechanical
properties of PVA fiber-reinforced CPC groups, whereas a one-way
ANOVA with a posthoc Tukey−Kramer multiple comparisons test
was used to compare the mechanical properties of the four
experimental groups selected for in vivo testing.
2.7.2. Analysis of Cyto- and Osteocompatibility. Statistical
analysis of the DNA quantification (n = 6) was performed using
two-way ANOVA with a posthoc Tukey−Kramer multiple compar-
isons test, while the histomorphometrical data (n = 3) were analyzed
using a one-way ANOVA with a Tukey−Kramer multiple
comparisons posthoc test. Statistical analysis of the crack length (n
= 3) was performed using a one-way ANOVA with a posthoc
Dunnett’s multiple comparison test. In addition, the comparison of
crack length between nonimplanted CPC and CPC/PVAMini speci-
mens was performed using an unpaired t test.
3. RESULTS
3.1. Characterization of CPC and PVA Fibers. X-ray
diffractograms of the hardened CPC reveal diffraction peaks
characteristic of hydroxyapatite (Powder Diffraction File
ICDD 9-432)38 for the fully set CPC, which confirms that
the phase transformation from α-TCP to hydroxyapatite was
complete upon full setting (Figure 1A). Diffractograms of
PVAKura and PVAMini fibers are similar in crystallinity, with
both showing a pronounced peak at 19.4° 2θ which is
indicative of the (101) reflection of PVA (Figure 1B).39
Figure 2. Effect of fiber length and weight concentration on the flexural strength (A, E), flexural modulus (B, F), work-of-fracture (C, G), and
representative stress vs strain curves (D, H) of CPCs reinforced with PVAKura fibers (A−D) or PVAMini fibers (E−H). Significant differences are
indicated by **p < 0.01, ***p < 0.001, and ****p < 0.0001. For comparative purposes, the work-of-fracture for the fiber-free control specimen was
measured as 0.020 ± 0.008 kJ m−2.
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3.2. Mechanical Properties of PVA Fiber-Reinforced
CPCs. Figure 2A−D illustrates the effect of fiber length and
concentration on the mechanical properties of CPCs
reinforced with PVA fibers modified with a hydrophobic
surface coating (PVAKura, Kuraray). Both the fiber length and
concentration improved the flexural strength more than 2-fold
(Figure 2A), with specimens containing 5 wt % fibers of 6 mm
in length exhibiting the greatest improvement of 21.5 ± 3.8
MPa compared to 6.6 ± 1.6 MPa for the fiber-free CPC (Table
S2). Further, doubling the fiber concentration from 2.5 to 5 wt
% improved the flexural strength of CPCs for both fiber
lengths (3 and 6 mm), whereas an increase in fiber length from
3 to 6 mm did not improve the strength of cements containing
2.5 wt % fibers. This observation suggests that fiber
concentration has a more pronounced effect on the flexural
strength than fiber length. No statistical difference in the
flexural modulus (Figure 2B) was observed for either of the
tested groups.
Cement toughness, on the other hand, nearly tripled from
3.2 ± 1.4 to 8.7 ± 2.5 kJ m−2 when both the fiber
concentration and length increased from 2.5 wt % 3 mm to
5 wt % 6 mm (Figure 2C). Moreover, the toughness for fiber-
free CPC specimens measured only 0.020 ± 0.008 kJ m−2,
meaning that the addition of 5 wt % 6 mm PVAKura fibers
substantially improved the toughness of CPCs by 435-fold.
Interestingly, the absence of a statistical difference among the 5
wt % 3 mm, 2.5 wt % 3 mm, and 2.5 wt % 6 mm groups
suggests that a threshold was reached for these fiber
conditions. The corresponding stress−strain curves shown in
Figure 2D confirm the effective toughening of CPCs using
PVAKura fibers, where the area calculated underneath these
curves corresponds to the toughness of the CPCs. We
observed that the 5 wt % 6 mm group reached a yield stress
of nearly 20 MPa before the cement began to deform
plastically followed by a strain-hardening phase. Contrary to
this behavior, all other groups only reached a stress of about
7−9 MPa before revealing a similar strain-hardening behavior.
For ceramics, this strain-hardening behavior is indicative of
ductile materials where multiple microcracks form in the
cement matrix without inducing complete failure, indicating
that the composite cement is able to withstand loads due to
several fiber-reinforcement mechanisms.34
Figure 2E−H shows the mechanical properties of CPCs
reinforced with hydrophilic, unmodified PVA fibers (PVAMini,
MiniFIBERS) fibers. Similar to CPCs reinforced with hydro-
phobic PVAKura fibers, both an increase in the length and
concentration of PVAMini fibers contributed to an improvement
in the flexural strength and toughness, where the 5 wt % 6 mm
group represented the highest values of 16.1 ± 3.7 MPa and
4.1 ± 1.6 kJ m−2 for flexural strength and toughness (Figure
2E,G), respectively. Interestingly, the flexural strength values
for both the PVAKura and PVAMini fiber-containing CPCs fall
Figure 3. Comparison of work-of-fracture values for CPC/PVAKura and CPC/PVAMini groups at 2.5 wt % (A) and 5 wt % (B). Significant
differences between experimental groups are indicated by *p < 0.05 and ****p < 0.0001. For comparative purposes, the work-of-fracture for the
fiber-free control specimen was measured as 0.020 ± 0.008 kJ m−2.
Figure 4. DNA quantification of MC3T3-E1 cells exposed to different concentrations of both PVAKura and PVAMini fibers at 0.1 (A), 1 (B), and 3
(C) mg mL−1 of fibers. The fiber-free group corresponds to a positive control. Significant differences are indicated by **p < 0.01 and ****p <
0.0001.
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within the range reported for trabecular bone (10−20 MPa),
irrespective of fiber length or concentration.40 Again, the
flexural modulus of CPCs was hardly affected by the
incorporation of PVAMini fibers (Figure 2F).
The stress−strain curves illustrated in Figure 2H shows a
similar pattern as observed for CPCs reinforced with PVAKura
fibers, where a maximum stress was reached at relatively low
strains followed by plastic deformation. However, after this
initial yield (i.e., stress at which plastic deformation occurs and
the matrix starts developing cracks), the stress drops at a faster
rate under lower strains when compared to CPCs reinforced
with PVAKura fibers. This behavior is indicative of tension-
softening and, consequently, results in lower toughness values.
These differences become more evident in Figure 3, where the
toughness of CPCs reinforced with either PVAKura or PVAMini
fibers is compared. The toughness of CPCs reinforced with 5
wt % of 6 mm long PVAKura fibers (8.7 ± 2.5 kJ m
−2) was more
than 2-fold higher than that of CPCs reinforced with the same
concentration of 6 mm long PVAMini fibers (4.1 ± 1.6 kJ m
−2).
CPCs reinforced with hydrophobically modified PVAKura fibers
displayed a strain-hardening behavior where the maximum
flexural strength was observed at ∼50% strain (Figure 2D),
whereas CPCs reinforced with hydrophilic PVAMini fibers
revealed a tension-softening behavior with maximum strength
values observed at a strain of only ∼15% (Figure 2H). A
summary of the flexural strength, flexural modulus, and
toughness for all CPC groups can be found in Table S2.
3.3. Cytocompatibility of PVA Fibers. To assess the
cytocompatibility of the selected PVA fibers, a DNA
quantification assay was performed for MC3T3-E1 cells
cultured in the presence of PVAMini or PVAKura fibers at
concentrations of 0.1, 1, and 3 mg mL−1. MC3T3-E1 cells were
also cultured in the absence of fibers (fiber-free) as a positive
control. Figure 4 shows that the DNA content increased with
time for both types of fibers. Up to 72 h of culture, cell
proliferation was equal for all experimental groups, while the
proliferation of cells cultured for 168 h in the presence of
PVAKura fibers was lower than fiber-free controls. PVAMini fibers
did not reduce the proliferation of the cultured cells at any of
the time points or fiber concentrations. The morphology of
both PVAKura and PVAMini fibers was not affected by cell
culture, as shown by SEM images in Figure S2 of the
Supporting Information.
3.4. Osseous Implantation of PVA Fiber-Reinforced
CPCs. Due to their superior cytocompatibility (Figure 4),
PVAMini fibers were selected for further testing of the
osteocompatibility of PVA fiber-reinforced CPCs using an
established femoral condyle implantation model in rabbits. A
PVAMini fiber concentration of 2.5 wt % was selected since a
higher fiber concentration did not result in higher toughness
values for CPCs reinforced with PVAMini fibers. Further, a fiber
length of 6 mm was selected since the toughness was
significantly higher (*p < 0.05) when compared to a CPC
reinforced with the same fiber concentration but with PVAMini
fibers 3 mm in length (Figure 3). The effect of PVAMini fibers
on the osteocompatibility of CPCs was studied for apatitic
CPCs which were either resorbable due to the incorporation of
porogens made of poly(D,L-lactic-co-glycolic acid) (PLGA)
porogens, or left nonresorbable (PLGA-free CPC). The
abbreviations and compositions of the four selected exper-
imental groups, i.e., (i) fiber- and PLGA-free CPC, (ii) fiber-
free CPC/PLGA, (iii) PLGA-free CPC/PVAmini, and (iv)
CPC/PLGA/PVAMini, are provided in Table 2. Prior to
implantation, the mechanical properties (Figure 5) and
morphology of the fractured specimens (Figure S1) were
characterized in more detail. Movies produced from 3D
reconstructed nanoCT images were also employed to evaluate
the dispersion of fibers and PLGA microparticles (Movies S1−
S4). SEM micrographs along with nanoCT videos indicated
that PLGA microparticles were dispersed homogeneously
Figure 5. Comparison of the flexural strength (A), flexural modulus (B), work-of-fracture (C), and representative stress vs strain curves (D) of the
four experimental groups selected for osseous implantation. Significant differences are indicated by *p < 0.05 and ***p < 0.001. For comparative
purposes, the work-of-fracture values for the fiber-free control (#) and fiber-free CPC/PLGA (##) specimens were measured as 0.020 ± 0.008 and
0.020 ± 0.004 kJ m−2, respectively.
ACS Biomaterials Science & Engineering Article
DOI: 10.1021/acsbiomaterials.9b00226
ACS Biomater. Sci. Eng. 2019, 5, 2491−2505
2497
throughout the matrix (Figure S1A-B, Movies S1 and S2)
whereas fibers tended to aggregate, particularly at higher
concentrations of fibers (Movie S4). SEM micrographs also
revealed substantial differences in the fracture plane and fiber−
matrix interface between CPC/PVAMini and CPC/PVAKura
specimens. Unlike CPC/PVAMini specimens, the fracture
plane of CPC/PVAKura specimens show fibers protruding
from the matrix along with the presence of fiber-shaped empty
tunnels (Figure S1D1,D2). Further, PVAKura fibers exhibited
surface abrasion whereas PVAMini fibers were abundantly
Figure 6. Representative histological images of fiber-free CPC, CPC/PVAMini, CPC/PLGA/PVAMini, and CPC/PLGA after 6 and 12 weeks of
osseous implantation in the femoral condyle of rabbits. Lowercase letters are magnifications of the corresponding uppercase letters, while H1, h1,
and g1 are magnifications of H, h, and g, respectively. The ROI is indicated by a white dashed circle. Orange scale bars correspond to 1000 μm, and
green scale bars correspond to 100 μm. Legend: OS, osteocytes; OB, osteoblasts; CPC, remaining cement; c, cracks in the cement matrix; BM,
bone marrow; NB, newly formed bone; F, PVAMini fibers; FT, fibrous tissue.
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coated with CPC particles, which suggests that unmodified
PVAMini fibers had a stronger affinity to the matrix than
PVAKura fibers which were pulled out from the matrix (Figure
S1C3,D3). These observations suggest that frictional resistance
against fiber pullout was lower for CPCs reinforced with
PVAKura fibers.
Generally, the addition of PLGA porogens reduced the
flexural strength and modulus of CPCs considerably (Figure
5A,B). Conversely, the addition of PVAMini fibers improved the
flexural strength to 9.1 ± 2.6 and 15.8 ± 2.5 MPa for CPC/
PLGA/PVAMini and CPC/PVAMini groups, respectively. The
toughness of CPCs increases substantially upon the incorpo-
ration of PVAMini fibers up to 2.4 ± 1.2 and 4.0 ± 1.1 kJ m
−2
for CPC/PLGA/PVAMini and CPC/PVAMini cements, respec-
tively (Figure 5C). Figure 5D revealed that fiber-free cements
(i.e., CPC and CPC/PLGA) experienced a brittle fracture
mode characterized by very low strain-to-failure (∼3−6%) and
toughness values (∼0.020 kJ m−2). In contrast, fiber-reinforced
cements (i.e., CPC/PLGA/PVAMini and CPC/PVAMini)
exhibited stress−strain curves indicative of quasibrittle
materials revealing tension-softening behavior.
Both the surgery and the postoperative periods were
uneventful for all animals. During the retrieval of the
specimens, after 6 and 12 weeks, no macroscopically adverse
tissue reactions were observed. An overview of the histological
images of all groups at both implantation periods is provided in
Figure 6. PLGA-free CPCs did not degrade, which limited the
ingrowth of new bone as observed in Figure 6A−D. In
contrast, PLGA-containing CPCs resorbed with time, resulting
in replacement of these CPCs with new bone (Figure 6E−H).
All groups showed intimate contact between the implanted
cement and the surrounding bone. Necrosis or alterations in
tissue morphology provoked by an adverse inflammatory
reaction were not observed. However, an inflammatory
response was detected around large agglomerates of PVAMini
fibers for the CPC/PLGA/PVAMini group (Figure 6H1),
characterized by narrow bands of fibrosis and a minimal
amount of fatty infiltrate. Polymorphonuclear inflammatory
cells were, however, hardly observed. In order to quantify the
biological response of fiber-containing CPCs relative to fiber-
free CPCs as controls, a semiquantitative scoring system
(Table S1) was used. The scoring results of this semi-
quantitative evaluation can be found in Table 3, which
indicated that both experimental groups can be classified as
nonirritant materials.
The amounts of CPC retention and newly formed bone in
the region-of-interest (ROI) were quantified histomorpho-
metrically as shown in Figure 7A,B. PLGA-free CPCs did not
degrade, resulting in almost 100% retention of CPC, while
PLGA-containing CPCs showed retention values of ∼50%
after 6 weeks and ∼25% after 12 weeks (Figure 7A).
Accordingly, hardly any bone was formed in these PLGA-
free CPCs (Figure 7B). In contrast, CPC/PLGA and CPC/
PLGA/PVAMini groups showed ∼20% of newly formed bone
after 6 weeks and ∼30% after 12 weeks (Figure 7B).
Occasionally, cracks were observed in the histological
sections of PLGA-free CPCs. To delineate whether these
cracks were present before implantation (due to processing of
the cement specimens) or if they were formed after
implantation, additional studies were performed. The length
of these cracks in sections of explanted specimens was
quantified in direct comparison to sections of nonimplanted
PLGA-free CPCs that were subjected to similar histological
processing steps as the implanted specimens (Figure 7C,D).
Evidently, cracks were also present in the sections of these
nonimplanted specimens (Figure 7C), and the length of these
cracks was similar to the cracks detected in the implanted
specimens (Figure 7D). Generally, crack length was lower for
CPCs reinforced with PVAMini fibers for nonimplanted
specimens.
4. DISCUSSION
PVA fibers were introduced into CPCs to achieve substantial
enhancement of their strength and toughness by enabling
transfer of loads from the matrix to the fibers. To this end,
PVA fibers were selected in view of the biocompatibility and
hydrophilicity of PVA as well as the high strength and stiffness
of commercially available PVA fibers. To vary the surface
chemistry of these PVA fibers, two types of commercially
available PVA fibers were tested, i.e., unmodified hydrophilic
PVAMini fibers and hydrophobically modified PVAKura fibers.
These fibers were added to CPCs at different lengths and
weight percentages, and their mechanical properties, morphol-
ogy, and molecular structure were thoroughly characterized.
Further, a cytocompatibility assay was performed to study the
in vitro biological response of the selected PVA fibers. Finally,
CPCs containing PVAMini fibers and/or PLGA porogens were
implanted into the femoral condyle of rabbits in order to
evaluate their osteocompatibility.
Typically, CPCs fail catastrophically in a brittle manner
without any preceding deformation which is unfavorable when
applied to load-bearing anatomical sites. Generally, the degree
of ductility and toughness of a material can be measured and
categorized into three different modes of failure: (i) brittle, (ii)
tension-softening for quasibrittle materials, and (iii) strain-
hardening for highly ductile materials. As failure modes shift
from brittle to tension-softening to strain-hardening, as
dictated by the behavior of their stress−strain curves, a
significant improvement in the strain-to-failure and toughness
can be observed.2
Unlike PVA-reinforced CPCs, the stress−strain curves of
unreinforced CPCs exhibited brittle failure at low strains (3−
6%) (Figure 5D) which corresponds to low toughness.12 With
the addition of PVAMini fibers, the stress−strain curves show
tension-softening behavior and the strain increases to 15−20%
resulting in improved toughness (Figure 2G,H). The ability of
fibers to improve the toughness of CPCs is caused by several
factors. The fibers both deflect cracks and bridge cracks
together, thereby hindering the propagation of the cracks and
dissipating energy throughout the matrix due to the nucleation
of new cracks. The amount and density of these microcracks
grow with increasing stress until a saturation level is reached
Table 3. Semiquantitative Evaluation of the Biological
Response of PVA Fiber-Reinforced CPCs after Osseous
Implantationa
scoring results
experimental group control group 6 weeks 12 weeks
CPC/PVAMini fiber-free CPC 1.3 ± 2.6 0.0 ± 2.3
CPC/PLGA/PVAMini CPC/PLGA 1.8 ± 1.9 0.5 ± 1.3
aDefinitions: nonirritant (0.0−2.9), slight irritant (3.0−8.9), moder-
ate irritant (9.0−15.0), severe irritant (>15.0). More details on this
scoring method derived from ISO 10993-6 can be found in the
Supporting Information (Table S1).
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after which previously arrested cracks propagate further.41
Energy is also absorbed and transferred from the matrix to the
fibers through frictional sliding at the fiber−matrix inter-
face.21,27,42 Frictional sliding is evidenced by fibers pulling out
from the matrix, which was more evident for CPC/PVAKura
cements (Figure S1D1,D2). Moreover, PVAKura fibers also
displayed surface abrasion which is indicative of the occurrence
of the interfacial slip (Figure S1D3) that allowed for efficient
dissipation of energy and higher toughness values.2,34
The ability of PVAKura fibers to prevent crack propagation is
greater when compared to PVAMini fibers, as evidenced by the
shift in the stress−strain curve behavior from tension-softening
for CPC/PVAMini specimens (Figure 2H) to strain-hardening
for CPC/PVAKura specimens (Figure 2D), resulting in greater
CPC toughness (Figure 3). Here, debonding at the fiber−
matrix interface during frictional sliding is improved due to the
hydrophobic coating which allows for more efficient transfer of
loads to the fibers.12,28 The result is a highly toughened and
bendable CPC that revealed extremely high toughness values
(8.7 ± 2.5 kJ m−2). These values exceed the highest values
reported so far for fiber-reinforced CPCs by Xu et al., where
carbon fibers were incorporated into CPCs to obtain
toughness values up to 6.5 kJ m−2,2,25 which stresses the
efficacy of PVA fibers for reinforcement of CPCs. Further, this
substantial improvement in the toughness and ductility of
CPCs reinforced with PVA fibers can expand their clinical
applicability to more load-bearing defect sites where conven-
tional unreinforced CPCs are unable to provide the
appropriate mechanical stability that is needed. More
specifically, certain procedures such as vertebroplasty,
kyphoplasty,8,9,14 long bone replacement,15 and fixation of
articulating prostheses16 or dental implants would become
areas of interest for PVA fiber-reinforced CPCs.
When comparing the toughness between the two PVA-
reinforced CPCs, CPCs reinforced with 5 wt % of hydro-
phobically modified PVAKura fibers were about 2 times tougher
than CPCs reinforced with unmodified hydrophilic PVAMini
fibers (Figure 3). We speculate that this observation can be
attributed to differences in the fiber hydrophobicity and,
consequently, the fiber−matrix affinity of the two fiber types.
Figure 7. Histomorphometric analysis of the percentage of remaining CPC (A) and percentage of newly formed bone (B) after 6 and 12 weeks of
osseous implantation, and representative histological images of cements containing cracks (C) and quantification of the total crack length per
specimen (D) for both nonimplanted and implanted specimens. Significant differences are indicated by **p < 0.01, ***p < 0.001, and ****p <
0.0001. The red scale bars correspond to 1000 μm.
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Since stress is transferred from the cement to the fiber during
frictional sliding at the fiber−matrix interphase, understanding
and tailoring this interphase interaction is of utmost
importance in order to engineer highly toughened
CPCs.2,12,28,43 If the interphase bond is too weak, the fiber
will pull out, whereas an excessively strong bond will result in
fiber rupture before energy dissipation can occur.26,44 PVAMini
fibers are inherently hydrophilic due to the presence of surface
hydroxyl groups, rendering them more susceptible to fiber
rupture rather than frictional sliding as the hydroxyl groups
bond strongly to the surrounding matrix.28,30 This is evidenced
by SEM micrographs of CPC/PVAMini cements after fracturing
(Figure S1C), where fibers do not protrude out of the matrix
fracture plane and fiber-shaped tunnels caused by fiber pullout
were not observed. This difference suggests that PVAMini fibers
were primarily ruptured rather than being pulled out from the
matrix. Further, the abundant presence of CPC particles on the
surface of PVAMini fibers (Figures S1C3) supports the fact that
PVAMini fibers have a strong affinity to the CPC matrix, thereby
compromising the toughening mechanism caused by frictional
sliding. Conversely, PVAKura fibers contain a hydrophobic
coating designed to reduce their hydrophilicity and, therefore,
their affinity with hydraulic cements, allowing for a more
efficient stress transfer to transpire.28 We speculate that this
reduced fiber−matrix affinity caused the improvement in
toughness and ductility for CPCs reinforced with hydrophobic
PVAKura fibers.
Scheffler and co-workers28 characterized the chemical
composition of this hydrophobic coating using FTIR and
reported the presence of ester and amide groups that are
attributed to cationic surface-active agents, while the presence
of acidic polyethylene was associated with long chain
polyethylene waxes. FTIR spectra of PVAKura and PVAMini
fibers (Figure S3) were similar except for the presence of a
peak around 2850 cm−1 which was only present in the PVAKura
fibers. This observation provides further evidence for the
presence of long chain polyethylene waxes that was associated
with the hydrophobic surface coating present on the PVAKura
fibers by Scheffler et al.,28 while the PVAMini fibers were
uncoated. The addition of this hydrophobic coating onto
hydrophilic PVA fibers has reportedly increased the tensile
strain capacity of PVA-reinforced Portland cements 10-fold by
reducing the affinity of hydrophilic PVA fibers and enhancing
frictional sliding.28−30,44 This approach of coating fibers to
tailor the fiber−matrix interfacial properties has also been
applied for CPCs. Specifically, dip-coating chitosan fibers in
gelatin45 or collagen46,47 has been successful at improving the
mechanical performance of CPCs, where the compressive
strength reportedly increased almost 2-fold47 and the
compressive modulus reached ∼1 GPa which is comparable
to that of wet canine bone.46
For both CPC/PVAMini and CPC/PVAKura cements, the
flexural strength and toughness improve when the fiber length
and concentration are increased. This trend has also been
observed for different fiber types such as carbon,25,42
PLGA,48,49 aramid, and polyglactin,42 among others.2,17
Therefore, optimizing the stress transfer during frictional
sliding is also dictated by the dimensions of the fibers. An
effective transfer of loads from the matrix to fibers can only be
achieved when fibers have a certain critical length which is
determined by the aspect ratio of the fibers.26 If fibers are of
insufficient length, then their lateral surface becomes too small
and the transfer of loads is inhibited.2 This principle explains
why the overall mechanical performance of CPCs reinforced
with 3 mm fibers was inferior compared to that of 6 mm fibers,
since reducing the fiber length from 6 to 3 mm causes a 2-fold
reduction in the aspect ratio (Table 1). However, this trend is
only observed for CPC/PVAKura cements. Instead, CPC/
PVAMini cements experience a practical upper limit where the
strength and toughness start to plateau off upon incorporation
of 5 wt % of 3 mm long fibers into the matrix. This practical
upper limit can be attributed to several factors. First, poor
transfer of loads due to nonoptimized fiber−matrix interfacial
properties implicates that more fibers are needed to improve
the mechanical properties of the cement. However, the use of
such large quantities of fibers can cause fiber aggregation and
inhomogeneous fiber dispersion.4,34,49 Poor fiber dispersion
and the formation of fiber aggregates is especially evident for
CPCs containing 5 wt % PVAMini fibers 6 mm in length (Movie
S4A,B). We speculate that the introduction of shear forces
during the mixing of the cement composite contributed to this
heterogeneous fiber dispersion. Second, fibers with a low
elastic modulus cannot carry higher loads2 since greater
differences between the elastic modulus of the fiber and matrix
cause additional strain at the interface, primarily in the less stiff
PVAMini fibers.
17 Limitations on the mechanical performance of
CPC/PVAMini cements can also be associated to the critical
fiber embedment length (lC), which is inversely proportional to
the fiber−matrix interfacial shear strength and dependent on
the fiber diameter.2 Since the diameter of PVAMini fibers is
nearly half that of PVAKura fibers (Table 1), 6 mm PVAMini
fibers might have surpassed their lC, thereby limiting any
improvement in the mechanical properties of CPCs. This is
further supported by the fact that 6 mm PVAKura fibers have an
aspect ratio that is nearly half that of 6 mm PVAMini fibers
(Table 1), yet they are still capable of more than doubling the
toughness of CPCs. This behavior can therefore be attributed
to two factors: (i) the improved fiber−matrix interfacial
properties of the hydrophobically coated PVAKura fibers and
(ii) the dimensions of the PVAMini fibers. Therefore, tailoring
and optimizing the fibers’ aspect ratio, lC, and affinity to the
matrix is of utmost importance when developing fiber-
reinforced CPCs for load-bearing applications.2,17,26
Finally, the addition of PVA fibers caused only minimal
decreases in the flexural modulus of CPCs, irrespective of the
type, length, or concentration. This is consistent with findings
of Burguera et al.48 who reported only minimal reductions in
the flexural modulus of CPC reinforced with 25% 8 mm PLGA
yarns. They attribute this slight reduction in the flexural
modulus to the fact that the PLGA fibers had a lower elastic
modulus than the CPC matrix, which has also been observed
elsewhere7,50 and is consistent with our findings. Moreover, the
addition of PLGA microparticles not only contributed to a
significant reduction in the flexural modulus but also the
flexural strength and toughness, as shown in Figure 5. This
reduction in flexural modulus is caused by the same
phenomenon observed for the PVA fibers, where the PLGA
microparticles have a lower modulus of elasticity than the
CPC. However, the amount of PLGA microparticles
introduced into the composite is significantly greater than
that of the fibers (i.e., maximum of 40 wt % PLGA versus 5 wt
% of fibers). Therefore, this effect is more pronounced for
PLGA-containing CPCs. Further, the spherical shape of PLGA
microparticles corresponds to a low aspect ratio, which
impedes any reinforcing effect. The reduction in flexural
strength and toughness caused by the introduction of PLGA
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microparticles suggests that PLGA microparticles act as defect
sites within the cement which facilitate crack formation and
propagation.
In order to evaluate the biological performance of the newly
developed PVA fiber-reinforced CPC, extensive in vitro and in
vivo studies were performed. As the biocompatibility of the
employed CPC matrix was confirmed numerous times in
previous studies,51−54 an in vitro cytocompatibility assay was
performed to understand the effect of PVAKura or PVAMini
fibers themselves on osteoblast-like cells.55 The results showed
that, for all selected concentrations, no significant differences
between the control and the experimental groups were
observed with up to 72 h of culture (Figure 4). These findings
suggest that potential release of compounds from both types of
PVA fibers did not affect the proliferation of the cultured cells
up to 72 h. However, the proliferation of cells exposed to
PVAKura fibers was significantly reduced as compared to the
fiber-free control after 168 h of culture, which could have been
caused by the release of cytotoxic components from the
hydrophobic surface coating and/or dimethyl sulfoxide from
the core of the PVAKura fibers,
56 which is a cytotoxic
organosulfur compound that is present in PVAKura fibers up
to 1%. However, the surface morphology of both types of PVA
fibers was not affected by extended cell culture (Figure S2).
Due to the superior cytocompatibility of PVAMini fibers,
PVAMini fibers were selected for further in vivo studies on the
osteocompatibility of PVA fiber-reinforced CPCs.
Our histological data confirmed the osteocompatibility of all
implanted groups (Figure 6), irrespective of the presence or
absence of PVAMini fibers. Apatitic CPCs are recognized as
osteocompatible biomaterials57,58 due to the fact that they
transform into nanocrystalline hydroxyapatite, the main
inorganic component present in native bone.1−5,57 Generally,
degradation of CPCs is facilitated by their intrinsic porosity. In
a previous study conducted by our group, Lodoso-Torrecilla et
al.59 measured the porosity of a CPC with a similar
formulation using helium pycnometry and reported a total
porosity of 48%. We also calculated the theoretical porosity of
our fiber-free CPC formulation to be 54%, assuming the
density of hydroxyapatite to be 3.156 g/mL. Therefore, we are
confident that our CPCs have a porosity range between 45%
and 55%. However, apatite-forming CPC has a very low
solubility at a physiological pH of 7.4, which hampers the
degradation of the implanted material and, consequently, the
regeneration of the bone defect. A common strategy to
accelerate the degradation of CPCs is to include acid-
producing PLGA microparticles in the CPC matrix.51−54
Shortly after implantation, the PLGA microparticles degrade,
creating a macroporous structure in the CPC matrix, while the
acidic lactic and glycolic acid byproducts of PLGA accelerate
the dissolution of the surrounding CPC matrix. In our study,
the addition of PLGA improved the degradation of the CPC to
∼50% of the original amount after 6 weeks and ∼70% after 12
weeks. These values are in accordance with previously reported
studies.51 In addition, the inclusion of PLGA allowed gradual
ingrowth of new bone into the interior of the implanted
cement resulting in ∼20% and ∼30% replacement after 6 and
12 weeks, respectively (Figure 7B). Regarding the degradation
of PVA fibers, it should be emphasized that both types of PVA
fibers were crystalline (Figure 1B) and heavily cross-linked
during their fabrication. Consequently, these fibers are not
biodegradable, which was confirmed by the absence of any
morphological changes of the PVA fibers after extensive cell
culture (Figure S2) and the histology images in which PVA
fibers can be clearly distinguished after 12 weeks of
implantation (Figure 6).
Interestingly, the percentage of new bone formation inside
the ROI of CPC/PLGA and CPC/PLGA/PVAMini specimens
is almost similar, which suggests that the presence of PVAMini
fibers does not affect the ingrowth of new bone. This
observation was confirmed by a detailed investigation of the
interphase between PVA fibers and newly formed bone, since
an intimate contact was revealed between bone and the surface
of PVAMini fibers (Figure 6g1,h1). Nevertheless, agglomer-
ations of PVAMini fibers induced a mild inflammatory response
(Figure 6H1) which can be explained by the fact that PVA,
unlike hardened apatitic CPC, is not an osteoconductive
material,58 thereby facilitating the formation of fibrotic tissue.
These results stress that dispersion of the PVA fibers should be
improved to avoid this fibrotic tissue response. Alternatively,
PVA fibers could also be functionalized with an osteoconduc-
tive layer such as hydroxyapatite58 or bioactive glass60 to
improve the capacity of PVA fibers to bind to bone, as reported
previously.
Finally, our findings showed that the amount of cracking of
nonimplanted cements versus cements implanted for 6 and 12
weeks (Figure 7D) was comparable, which suggests that preset
cements cracked during their synthesis, most likely due to
shrinkage caused by excessive drying prior to implantation, a
phenomenon that was previously observed in other types of
cements61 as well as CPCs.62 As before, CPC/PVAMini samples
cracked significantly less than their fiber-free counterparts
(Figure 7D), which confirms again that the inclusion of PVA
fibers successfully arrested crack propagation.
5. CONCLUSIONS
Mechanical reinforcement of CPCs was successfully achieved
by incorporating PVA fibers into the cement matrix. PVA fiber-
reinforced CPCs exhibited higher flexural strength and
toughness values than reported in the literature for fiber-
reinforced CPCs, with this effect increasing with increasing
fiber length and concentration. Moreover, CPCs reinforced
with both PLGA porogens and PVA fibers combined the
reinforcing effect of PVA fibers with the resorbability induced
by PLGA microparticles, thereby allowing for ingrowth of bone
into tough PVA fiber-reinforced CPCs. Therefore, it was
concluded that the inclusion of PVA fibers into nonresorbable
CPCs as well as PLGA-containing resorbable CPCs strongly
improved their strength and toughness without compromising
their osteocompatibility. These findings render PVA fiber-
reinforced CPCs clinically relevant for applications in load-
bearing skeletal sites.
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Movie S2 showing 3D reconstructed NanoCT video of a
CPC/PLGA/PVAMini specimen containing a fiber
concentration of 2.5 wt % with a fiber length of 6 mm
(MP4)
Movie S3A showing 3D reconstructed NanoCT video of
a CPC/PVAMini specimen containing a fiber concen-
tration of 2.5 wt % with a fiber length of 6 mm, with the
CPC matrix in blue and the fibers in green (MP4)
Movie S3B showing the fibers alone in green (MP4)
Movie S4A showing 3D reconstructed NanoCT video of
a CPC/PVAMini specimen containing a fiber concen-
tration of 5 wt % with a fiber length of 6 mm with the
CPC matrix in blue and the fibers in green (MP4)
Movie S4A showing the fibers alone in green (MP4)
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